Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid

Journal of Medicinal Chemistry
Michael PodvinecTorsten Schwede

Abstract

Dengue fever is a viral disease that affects 50-100 million people annually and is one of the most important emerging infectious diseases in many areas of the world. Currently, neither specific drugs nor vaccines are available. Here, we report on the discovery of new inhibitors of the viral NS5 RNA methyltransferase, a promising flavivirus drug target. We have used a multistage molecular docking approach to screen a library of more than 5 million commercially available compounds against the two binding sites of this enzyme. In 263 compounds chosen for experimental verification, we found 10 inhibitors with IC(50) values of <100 microM, of which four exhibited IC(50) values of <10 microM in in vitro assays. The initial hit list also contained 25 nonspecific aggregators. We discuss why this likely occurred for this particular target. We also describe our attempts to use aggregation prediction to further guide the study, following this finding.

References

Jul 15, 1979·Virology·G R Cleaves, D T Dubin
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Oct 29, 2000·Advances in Virus Research·Y Furuichi, A J Shatkin
Jan 10, 2003·Molecular Biology and Evolution·S Susanna TwiddyAndrew Rambaut
May 3, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·María G Guzman, Gustavo Kouri
Jul 25, 2003·Journal of Medicinal Chemistry·Ali J RyanChun-wa Chung
Oct 3, 2003·Journal of Medicinal Chemistry·James SeidlerBrian K Shoichet
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Dec 21, 2004·Nature Reviews. Microbiology·Suchetana MukhopadhyayMichael G Rossmann
Jan 26, 2005·Journal of Chemical Information and Modeling·John J Irwin, Brian K Shoichet
Jan 13, 2006·Nature Chemical Biology·Brian Y FengBrian K Shoichet
Jun 24, 2006·Drug Discovery Today·Brian K Shoichet
Dec 8, 2006·Journal of Medicinal Chemistry·Brian K Shoichet
Dec 28, 2006·Nature Protocols·Brian Y Feng, Brian K Shoichet
Feb 3, 2007·Journal of Virology·Yangsheng ZhouHongmin Li
Apr 24, 2007·Journal of Medicinal Chemistry·Brian Y FengChristopher P Austin
Apr 24, 2007·Journal of Chemical Information and Modeling·Max W ChangRichard K Belew
Jun 2, 2007·Journal of Molecular Evolution·Eleca J Dunham, Edward C Holmes
Jun 15, 2007·Nature Reviews. Microbiology·Stephen S WhiteheadBrian R Murphy
Aug 31, 2007·Journal of Chemical Information and Modeling·Vinod KasamMartin Hofmann-Apitius
Jan 10, 2008·JAMA : the Journal of the American Medical Association·David M Morens, Anthony S Fauci
Feb 12, 2008·Lancet·E A Gould, T Solomon
Mar 13, 2008·Journal of Medicinal Chemistry·Kerim BabaogluBrian K Shoichet
Apr 4, 2008·Nucleic Acids Research·Ian M OvertonGeoffrey J Barton
Jun 24, 2008·Antiviral Research·Hongping DongPei-Yong Shi
Jul 23, 2008·Current Opinion in Microbiology·Rushika Perera, Richard J Kuhn
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Qing-Yin WangSubhash G Vasudevan
Jun 9, 2009·Antiviral Research·Mario MilaniMartino Bolognesi

❮ Previous
Next ❯

Citations

Jun 11, 2011·Journal of Computer-aided Molecular Design·Jakyung Yoo, José L Medina-Franco
Oct 12, 2012·Journal of Computer-aided Molecular Design·Ori KalidSharon Shacham
Apr 25, 2012·Journal of Medicinal Chemistry·Francesca CurreliAsim K Debnath
Jun 29, 2013·Nature Communications·Jessica L Childs-DisneyMatthew D Disney
Sep 22, 2011·PloS One·Maude Tremblay-LétourneauMartin Bisaillon
Oct 8, 2013·PloS One·Ryan G ColemanBrian K Shoichet
Jun 29, 2011·Future Medicinal Chemistry·Chenzhong LiaoMarc C Nicklaus
Jun 26, 2013·Future Medicinal Chemistry·Marcin ZiemniakJacek Jemielity
Sep 20, 2011·Frontiers in Biology·Lihui LiuHongmin Li
Dec 5, 2013·Viruses·Siew Pheng Lim, Pei-Yong Shi
Jul 31, 2012·Antiviral Research·François FerronBruno Canard
Sep 26, 2013·Drug Discovery Today. Technologies
Oct 1, 2011·Wiley Interdisciplinary Reviews. RNA·Moheshwarnath IssurMartin Bisaillon
Dec 24, 2010·Annals of the New York Academy of Sciences·Anil K Agarwal, Colin W G Fishwick
Nov 14, 2015·ACS Chemical Biology·Matthieu Schapira
Jan 28, 2015·RNA Biology·Magdalena ByszewskaJanusz M Bujnicki
Jan 15, 2011·Antiviral Chemistry & Chemotherapy·Justin G JulanderSujan Shresta
Oct 6, 2019·SLAS Discovery·Shane M BukerP Ann Boriack-Sjodin
Jan 17, 2020·Molecular Informatics·Subrata PramanikKlaus Heese
Jul 25, 2019·Frontiers in Cellular and Infection Microbiology·Megan ChesnutDavid Pamies
Nov 18, 2017·Archives of Virology·Camyla Alves LeonelJaqueline Maria Siqueira Ferreira
Apr 8, 2020·Chemistry : a European Journal·Renata KasprzykJacek Jemielity
Dec 6, 2018·Current Medicinal Chemistry·Adib Afandi AbdullahChoon Han Heh
Dec 1, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiao-Huan LiuTao Wang
Dec 31, 2020·Pharmaceuticals·K Eurídice Juárez-MercadoJosé L Medina-Franco
Jun 26, 2010·Journal of Medicinal Chemistry·Luke R OdellAdam McCluskey
Jun 6, 2013·Journal of Chemical Information and Modeling·Jacob D DurrantJ Andrew McCammon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.